Emla®-cream as pain relief during pneumococcal vaccination

Emla®-cream as pain relief during pneumococcal vaccination AbstractBackgroundPneumococcal vaccination for children was introduced in Sweden in 2009. For more than two decades, previous studies have shown that anesthetic cream Emla® has good effect in reducing vaccine-related pain. Even today health care workers claim “children forget quickly, and it (the pain) goes away”, this ignorance causes pain in children not treated or treated in one for the child and his guardians satisfactorily way.PurposeThe purpose of this intervention study was to compare the effect of Emla® cream for pain relief or no pain relief in connection with the first pneumococcal vaccination at three months of age in child healthcare.MethodThe study included 72 children who, at three months of age received their first pneumococcal vaccine (Prevenar 13®). The children were randomized, 36 children received pneumococcal vaccination with placebo cream and the other 36 children received the intervention, Emla®-cream.ResultThe result shows that anesthetic cream Emla® significantly reduces pain when FLACC is used as a pain assessment tool and the children begin to cry significantly later than children who received placebo cream. An interesting secondary finding of the study was that the younger the child was the stronger was the reaction to pain.ConclusionThe infant needs to be treated as an autonomous individual with full integrity. We recommend Emla® to be used and applied in vaccination when the children are three-, five- and twelve months. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Scandinavian Journal of Pain de Gruyter

Emla®-cream as pain relief during pneumococcal vaccination

Loading next page...
 
/lp/degruyter/emla-cream-as-pain-relief-during-pneumococcal-vaccination-8b4fAJJZ2z
Publisher
De Gruyter
Copyright
© 2016 Scandinavian Association for the Study of Pain
ISSN
1877-8860
eISSN
1877-8879
D.O.I.
10.1016/j.sjpain.2016.05.021
Publisher site
See Article on Publisher Site

Abstract

AbstractBackgroundPneumococcal vaccination for children was introduced in Sweden in 2009. For more than two decades, previous studies have shown that anesthetic cream Emla® has good effect in reducing vaccine-related pain. Even today health care workers claim “children forget quickly, and it (the pain) goes away”, this ignorance causes pain in children not treated or treated in one for the child and his guardians satisfactorily way.PurposeThe purpose of this intervention study was to compare the effect of Emla® cream for pain relief or no pain relief in connection with the first pneumococcal vaccination at three months of age in child healthcare.MethodThe study included 72 children who, at three months of age received their first pneumococcal vaccine (Prevenar 13®). The children were randomized, 36 children received pneumococcal vaccination with placebo cream and the other 36 children received the intervention, Emla®-cream.ResultThe result shows that anesthetic cream Emla® significantly reduces pain when FLACC is used as a pain assessment tool and the children begin to cry significantly later than children who received placebo cream. An interesting secondary finding of the study was that the younger the child was the stronger was the reaction to pain.ConclusionThe infant needs to be treated as an autonomous individual with full integrity. We recommend Emla® to be used and applied in vaccination when the children are three-, five- and twelve months.

Journal

Scandinavian Journal of Painde Gruyter

Published: Jul 1, 2016

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off